Two new large studies investigate Finerenone in type 2 diabetes.
Clinical Trials
Learn about clinical trials for new diabetes treatments, technology, and care programs that may be recruiting people with diabetes in your area.
38 readers recommended
New trial aims to make U500 (more concentrated) insulin easier to take.
36 readers recommended
Currently recruiting in people newly diagnosed with type 1.
42 readers recommended
Testing TypeZero’s inControl artificial pancreas, six months at a time.
49 readers recommended
The 338-patient, Dexcom-sponsored DIaMonD Study aims to find out.
34 readers recommended
Currently enrolling! How does the pill form of this drug class compare to injected GLP-1s?
37 readers recommended
What are the implications for other injected GLP-1 agonist drugs?
32 readers recommended
Program designed for Medicaid and uninsured individuals at risk for diabetes. Omada Health recently announced the launch of Prevent for Underserved Populations. The new...
46 readers recommended
Enrolling at over 140 sites worldwide. Can it reduce A1c and insulin use and improve time-in-range?
33 readers recommended
Find nearby T1D, T2D, gestational diabetes, and complications trials with new clinical trials matching tool launched by JDRF and TrialReach
22 readers recommended
A six-month study of Diasome Pharmaceuticals’ HDV Insulin in Type 1 Diabetes
30 readers recommended
Recruiting participants in Boston at the Joslin Diabetes Center
41 readers recommended
Trial results testing sotagliflozin and Farxiga in type 1 diabetes show greater A1c lowering and weight loss, plus continued conversation about small risk of DKA
43 readers recommended
Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health
45 readers recommended
Comparing Medtronic’s MiniMed 670G to injections and pumps in people with type 1 diabetes, with and without CGM; enrollment to open in May at some trial locations
55 readers recommended
A real-world trial in 3,000+ participants currently enrolling participants with type 2 diabetes
39 readers recommended
A six-week study of Tandem’s first automated insulin delivery device with Dexcom’s G5 CGM
36 readers recommended
Two new studies will investigate whether SGLT-2 inhibitor Jardiance impacts heart failure in people with and without diabetes. Jardiance is already approved to lower A1C...
47 readers recommended
A new study is investigating whether higher doses of injectable GLP-1 agonist Trulicity (dulaglutide) are more effective; it is recruiting 1,800 participants with type 2...
54 readers recommended
A new trial will test if the once-weekly injectable, Bydureon, is also safe and effective in adolescents.